The expression of EED, EZH2, STMN1 and JUNB [31] was closely associated with miR-101 and GEPIA analysis revealed that the elevated expression of these miR-101-responsive gene signatures was correlated with poor prognosis in HCC patients (Fig. 1E). This evidence concerns the gene EZH2 and hepatocellular carcinoma.